Cell Line and Augument Cellular Uptake Study of Statistically Optimized Sustained Release Capecitabine Loaded Eudragit S100/PLGA(poly(lacticco- glycolic acid)) Nanoparticles for Colon Targeting.
Sign Up to like & getrecommendations! Published in 2017 at "Current drug delivery"
DOI: 10.2174/1567201813666160817150621
Abstract: BACKGROUND Capecitabine, an anti cancer drug, has a very short drug elimination half-life (0.49 to 0.89 h). High doses and absence of targeting ability in the colon region may lead to more side effects to… read more here.
Keywords: eudragit s100; uptake study; drug; s100 plga ... See more keywords